Breaking News Instant updates and real-time market news.

FLR

Fluor

$18.60

0.3 (1.64%)

11:45
08/13/19
08/13
11:45
08/13/19
11:45

Fluor call volume above normal and directionally bullish

Bullish option flow detected in Fluor with 2,917 calls trading, 3x expected, and implied vol increasing over 1 point to 48.15%. Oct-19 20 calls and Oct-19 20 puts are the most active options, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 0.63. Earnings are expected on October 31st.

FLR Fluor
$18.60

0.3 (1.64%)

05/07/19
DADA
05/07/19
NO CHANGE
Target $32
DADA
Neutral
Fluor price target lowered to $32 from $43 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on Fluor to $32 and kept his Neutral rating after its Q1 earnings miss, a cut in its FY19 guidance, and a management transition disclosed last week. The analyst says the new CEO inherits "ongoing problem projects", some of which have existed for over a year, adding that convincing investors that Fluor's expanding backlog is "not a liability" will be key. Thielman intends to monitor for the new management to announce new strategies that Fluor may pursue to generate more consistent profitability.
05/07/19
05/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich seeing an unclear medium-term margin outlook amid the company's CEO transition and further project writedowns in Q1. 2. Gardner Denver (GDI) downgraded to Neutral from Buy at UBS with analyst Damian Karas downgraded saying the shares are due for a "breather" following the recent run. 3. Boeing (BA) downgraded to Equal Weight from Overweight at Barclays with analyst David Strauss expecting the recovery of 737 Max production to take longer than expected. 4. Discover (DFS) downgraded to Perform from Outperform at Oppenheimer with analyst Dominick Gabriele seeing limited upside in the shares following the rally year-to-date now that his estimates are in-line with the consensus. 5. Cambrex (CBM) downgraded to Outperform from Strong Buy at First Analysis with analyst Steven Schwartz saying the company's valuation multiple is now in-line with peers following the recent share price appreciation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
ADAM
07/10/19
NO CHANGE
Target $35
ADAM
Hold
Fluor price target raised to $35 from $32 at Canaccord
Canaccord analyst Yuri Lynk raised his price target for Fluor to $35 from $32 and reiterated a Hold rating ahead of the company's second quarter results. In a research note to investors, Lynk says he "just doesn't have the visibility" to recommend the stock here with a new chairman, a new CEO, a new CFO and a "couple" of troubled projects in backlog. Lynk says he will remain on the sidelines until he has confidence in management's ability to execute on Fluor's book of business.
08/05/19
FBCO
08/05/19
NO CHANGE
Target $31
FBCO
Outperform
Fluor price target lowered to $31 from $41 at Credit Suisse
Credit Suisse analyst Jamie Cook lowered his price target for Fluor to $31 from $41 after the company reported $714M in charges associated with projects costs as well as restructuring charges in the Diversified Services segment. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

NCNA

NuCana

$7.25

0.25 (3.57%)

08:07
08/20/19
08/20
08:07
08/20/19
08:07
Hot Stocks
NuCana announces suspension of enrollment in Phase III ACELARATE study »

NuCana reported that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

SQ

Square

$64.11

1.2 (1.91%)

, PYPL

PayPal

$107.64

1.52 (1.43%)

08:07
08/20/19
08/20
08:07
08/20/19
08:07
Recommendations
Square, PayPal analyst commentary  »

Square Cash App had…

SQ

Square

$64.11

1.2 (1.91%)

PYPL

PayPal

$107.64

1.52 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 10

    Sep

  • 27

    Oct

  • 06

    Nov

BYND

Beyond Meat

$144.44

-0.49 (-0.34%)

08:06
08/20/19
08/20
08:06
08/20/19
08:06
Hot Stocks
C.A. Fortune announces National Sales Agency partnership with Beyond Meat »

C.A. Fortune announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTLK

Outlook Therapeutics

$1.95

-0.05 (-2.50%)

08:05
08/20/19
08/20
08:05
08/20/19
08:05
Hot Stocks
Outlook Therapeutics completes patient enrollment for NORSE 1 Phase 3 trial »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 12

    Sep

BTAI

BioXcel Therapeutics

$8.73

-0.5 (-5.42%)

08:04
08/20/19
08/20
08:04
08/20/19
08:04
Hot Stocks
BioXcel Therapeutics awarded grant by U.S. DoD for BXCL501 development »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLY

Soliton

$11.07

0.63 (6.03%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Soliton announces results from preclinical studies of RAP treatment »

Soliton announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$2.71

(0.00%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Mersana Therapeutics intitiates expansion portion of Phase 1 study of XMT-1536 »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGR

Eiger BioPharmaceuticals

$10.43

0.16 (1.56%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
Eiger BioPharmaceuticals receives FDA BTD for for peginterferon lambda »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.44

-0.81 (-11.17%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
LiqTech announces SPA to acquire BS Plastic »

LiqTech International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

CACI

CACI

$209.74

1.42 (0.68%)

08:01
08/20/19
08/20
08:01
08/20/19
08:01
Upgrade
CACI rating change  »

CACI upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VST

Vistra Energy

$23.68

-0.02 (-0.08%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Hot Stocks
Vistra Energy to acquire Ambit Energy for $475M »

Vistra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

CNHI

CNH Industrial

$9.37

0.555 (6.30%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Options
CNH Industrial call buyer realizes 150% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$143.66

-0.23 (-0.16%)

07:59
08/20/19
08/20
07:59
08/20/19
07:59
Recommendations
Salesforce analyst commentary  »

Salesforce sets up for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:57
08/20/19
08/20
07:57
08/20/19
07:57
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$61.34

0.14 (0.23%)

07:55
08/20/19
08/20
07:55
08/20/19
07:55
Downgrade
Vornado rating change  »

Vornado downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

07:55
08/20/19
08/20
07:55
08/20/19
07:55
General news
U.S. chain store sales fell 0.2% in the week ended August 17 »

U.S. chain store sales…

ANAB

AnaptysBio

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Recommendations
AnaptysBio analyst commentary  »

Cantor says AnaptysBio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Initiation
Sunnova Energy initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:50
08/20/19
08/20
07:50
08/20/19
07:50
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

IMMU

Immunomedics

$14.83

-0.11 (-0.74%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Initiation
Immunomedics initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

LVS

Las Vegas Sands

$54.67

2.28 (4.35%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Downgrade
Las Vegas Sands rating change  »

Las Vegas Sands cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SILK

Silk Road Medical

$40.85

0.28 (0.69%)

07:44
08/20/19
08/20
07:44
08/20/19
07:44
Initiation
Silk Road Medical initiated  »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

07:42
08/20/19
08/20
07:42
08/20/19
07:42
Downgrade
iQIYI rating change  »

iQIYI downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNET

ChinaNet Online

$1.50

0.135 (9.89%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Hot Stocks
ChinaNet CEO says will continue to integrate blockchain, AI tech into products »

CEO Handong Cheng,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.